A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes

Diabetologia

Volumn 58, Issue 12, 2015, Pages 2877-2884

  Stefan, Norbert ^a,b,c   Staiger, Harald ^a,b,c   Wagner, Robert ^a,b,c   Machann, Jürgen ^a,b,c   Schick, Fritz ^a,b,c   Häring, Hans Ulrich ^a,b,c   Fritsche, Andreas ^a,b,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Impaired glucose tolerance; Insulin secretion; Insulin sensitivity; Lifestyle intervention; Nonalcoholic fatty liver disease; Normal glucose regulation; Prediabetes

Indexed keywords

GLUCOSE; INSULIN; FAT; GLUCOSE BLOOD LEVEL;

ADULT; AGE; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FAT CONTENT; FAT MASS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WAIST CIRCUMFERENCE; BLOOD; BODY COMPOSITION; GLUCOSE TOLERANCE TEST; LIFESTYLE; LIVER; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PREDIABETIC STATE; RISK;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; FATS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; LIVER; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; NON-ALCOHOLIC FATTY LIVER DISEASE; PHENOTYPE; PREDIABETIC STATE; RISK;

EID: 84946495886     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3760-z     Document Type: Article

References (38)

1. Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
2. Lindström J, Ilanne-Parikka P, Peltonen M et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679
3. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
4. Knowler WC, Fowler SE et al (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677–1686
5. Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544
6. Li G, Zhang P, Wang J et al (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371:1783–1789
7. Lindström J, Peltonen M, Eriksson JG et al (2013) Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56:284–293
8. Schwarz PE, Greaves CJ, Lindström J, Yates T, Davies MJ (2012) Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nat Rev Endocrinol 8:363–373
9. Ramachandran A, Snehalatha C, Ram J et al (2013) Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 1:191–198
10. Glechner A, Harreiter J, Gartlehner G et al (2015) Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia 58:242–254
11. Lindström J, Peltonen M, Eriksson JG et al (2008) Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care 31:857–862
12. Perreault L, Pan Q, Mather KJ et al (2012) Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379:2243–2251
13. Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF. (2009) Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 32:1583–1588
14. Kantartzis K, Thamer C, Peter A et al (2009) High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 58:1281–1288
15. Kantartzis K, Machann J, Schick F et al (2011) Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 54:864–868
16. Lehmann R, Franken H, Dammeier S et al (2013) Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36:2331–2338
17. Stefan N, Thamer C, Staiger H et al (2007) Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. J Clin Endocrinol Metab 92:1827–1833
18. Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942
19. Machann J, Thamer C, Stefan N et al (2010) Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology 257:353–363
20. Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462–468
21. Genuth S, Alberti KG, Bennett P et al (2003) Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167
22. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
23. Thamer C, Machann J, Stefan N et al (2007) High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity 15:531–538
24. Nanditha A, Ram J, Snehalatha C et al (2014) Early improvement predicts reduced risk of incident diabetes and improved cardiovascular risk in prediabetic Asian Indian men participating in a 2-year lifestyle intervention program. Diabetes Care 37:3009–3015
25. Stefan N, Häring HU (2011) The metabolically benign and malignant fatty liver. Diabetes 60:2011–2017
26. Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58:1212–1221
27. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379:2279–2290
28. Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083
29. Cefalu WT (2014) A “spoonful of sugar” and the realities of diabetes prevention! Diabetes Care 37:906–908
30. Dunkley AJ, Bodicoat DH, Greaves CJ et al (2014) Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 37:922–933
31. Kahn R, Davidson MB (2014) The reality of type 2 diabetes prevention. Diabetes Care 37:943–949
32. Uusitupa M, Lindi V, Louheranta A et al (2003) Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes 52:2532–2538
33. Gastaldelli A, Kozakova M, Højlund K et al (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537–1544
34. Finucane FM, Sharp SJ, Hatunic M et al (2014) Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals. Diabetol Metab Syndr 6:43
35. Roden M (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes -- pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2:335–348
36. Cusi K (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142:711–725.e6
37. Stefan N, Häring HU (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol 9:144–152
38. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F (2009) Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51:433–445